Clear Street’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Clear Street’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$2	–	1154
2025 Q4	$2	Buy	+100	New	+$3	﹤0.01%	925
2025 Q2	–	Sell	-100	Closed	-$5	–	708
2025 Q1	$5	Buy	+100	New	+$7	﹤0.01%	567
2024 Q4	–	Sell	-100	Closed	-$7	–	619
2024 Q3	$7	Buy	+100	New	+$8	﹤0.01%	699
2023 Q4	–	Sell	-100	Closed	-$17	–	920
2023 Q3	$17	Sell	100 -279,940	-100%	-$44.1K	﹤0.01%	1065
2023 Q2	$53.2K	Buy	280,040 +100	+0%	+$18	﹤0.01%	425
2023 Q1	$45.7K	Buy	+279,940	New	+$54K	﹤0.01%	257

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street's RCKTW Position: Q1 2026 in Review

Clear Street sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q1 2026, closing a stake of 100 shares — an estimated $2 sold.

Clear Street first reported a position in RCKTW in Q1 2023 and held it in 6 quarters. The position peaked at $53.2K in Q2 2023. 10 funds tracked by Wall St. Rank hold RCKTW as of Q1 2026.

Clear Street reported no remaining Rocket Pharmaceuticals Warrant position as of Q1 2026 after selling out during the quarter.
Clear Street sold 100 Rocket Pharmaceuticals Warrant shares in Q1 2026, an estimated $2.
Clear Street first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and held it in 6 quarters.
Clear Street's Rocket Pharmaceuticals Warrant position peaked at $53.2K in Q2 2023.
10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.